MOB Moberg Pharma AB (publ)

0.9676USD9.830 SEK · STO-1.21%Mkt Cap: 45.65M USDP/E: —

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly k…

Institutional holders1 on file

Key Statistics

Company
Market Cap45.65M USD
Enterprise Value22.13M USD
Revenue (TTM)1.82M USD
Gross Profit755.94K USD
Net Income (TTM)-2.68M USD
Revenue/Share0.04 USD
Last Price0.9676 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees5
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0020353928
Valuation
P/E (Trailing)—
P/E (Forward)-49.15
PEG—
EV/EBITDA-13.09
EV/Revenue12.13
P/S25.02
P/B0.65
EPS (TTM)-0.04 USD
EPS (Forward)-0.02 USD
52W Range
0.801228% of range1.390
52W High1.390 USD
52W Low0.8012 USD
Profitability
Gross Margin56.73%
Oper. Margin-96.50%
EBITDA Margin-92.72%
Profit Margin-201.18%
ROE-4.09%
ROA-3.99%
ROIC-6.40%
ROCE-4.20%
Growth
Revenue Growth44.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.72M USD
CapEx (TTM)4.25M USD
FCF Margin-137.89%
FCF Yield-5.51%
Net Debt-20.00M USD
Net Debt/EBITDA11.83
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio13.45
Quick Ratio13.19
Book Value/Sh1.50 USD
Cash/Share0.46 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 4, 2019
Pay Date—
Splits
Last Split1:10
Split DateMay 24, 2023
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.476 USD
Upside (mean)+52.6%
Target Range1.476 USD – 1.476 USD
# Analysts1
Ownership
Shares Out.47.18M
Float34.99M
Insiders21.05%
Institutions19.36%
Technical
SMA 501.075 (-10.0%)
SMA 2001.029 (-6.0%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)70.61K
Avg Vol (10d)76.98K
Technical Indicators
RSI (14)33.6
MACD-0.2739
MACD Signal-0.2009
MACD Hist.-0.0730
BB Upper1.120 USD
BB Middle1.040 USD
BB Lower0.9600 USD
BB Width15.36%
ATR (14)0.0448 USD
Vol Ratio (20d)0.61x

About Moberg Pharma (STO: MOB)

›

Moberg Pharma (STO: MOB) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 5 employees.

The shares were at 9.830 SEK on 19 November 2026, up 2.0% over 52 weeks. Its 52-week range is 8.140 SEK to 14.12 SEK: the price is 30.4% below the high and 20.8% above the low.

Its market capitalisation is 463.79M SEK.

Moberg Pharma reports return on equity of -4.1%, an operating margin of -96.5% and revenue up 44.2% year over year.

It holds more cash than debt, a net cash position of 203.22M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 15.00 SEK is 52.6% above the current price.